Your Fat Loss Sprint Planner
GLP-1s suppress appetite hormonally. When they stop, the hunger returns. The sprint builds the protein habits, the tracking, and the structure that work without the prescription.
Wilding et al. (2022) followed Wegovy participants after stopping the medication. Within one year, mean weight regain was 11.6% of initial body weight — approximately two-thirds of what had been lost. This is not a personal failure. It reflects the mechanism: GLP-1 medications suppress appetite hormonally. When the medication stops, the hormonal environment returns toward baseline.
The question is not whether some regain is likely — it is. The question is what you can do to minimise it and extend the fat loss window.
The FLS creates a deep caloric deficit through a structured protocol — not pharmaceutical appetite suppression. It trains the behaviours (protein targeting, strength training, structured meal tracking, supplement protocol) that work independently of medication.
The FLS can be used as a structured reset if weight begins to drift upward — a 14-day sprint to recapture the progress, followed by a Maintenance Phase that builds independent sustainable habits.
The 14-day mandatory Maintenance Phase after every sprint is designed to recalibrate appetite hormones, NEAT, and behavioural habits at a new set point — the same recovery challenge that GLP-1 withdrawal creates, but structured into the protocol rather than left unmanaged.
| GLP-1 Medication | Lipoly Fat Loss Sprint | |
|---|---|---|
| Appetite suppression | Hormonal (GLP-1 receptor) | Nutritional ketosis (endogenous) |
| Behavioural habit building | Not built in | Mandatory: daily tracking, training, supplementation |
| Post-protocol structure | None | 14-day Maintenance Phase |
| Independence from ongoing treatment | None | Complete — protocol ends, habits remain |
| Protein targeting | Not specified | 2.2–3.0 g/kg LBM — lean mass protective |
| Training | Not specified | 2x/week strength — required |
The mechanisms of GLP-1 weight loss and PSMF weight loss are different — but the physiological outcomes share important parallels:
Nackers et al. (2010) and Purcell et al. (2014) both confirm that what determines long-term weight maintenance is post-protocol behaviour — not the mechanism of loss. The sprint builds that behaviour explicitly.
Consult your doctor before stopping any GLP-1 medication. Lipoly does not replace prescribed treatment.
The Protocol
Your macros, protein target, and sprint length aren't guesses — they're set by the Fat Loss Sprint, a protocol built on 50+ years of clinical research. See how it works, and how it compares to every other diet.
Free 7-day trial · No charge today · Cancel anytime